prevalence of gastroesophageal reflux during childhood and teenage years in France
Study identifier:NIS-GFR-DUM-2008/1
ClinicalTrials.gov identifier:N/A
EudraCT identifier:N/A
CTIS identifier:N/A
Study Complete
Official Title
prevalence of gastroesophageal reflux during childhood and teenage years in France
Medical condition
Gastroesophageal Reflux
Phase
-
Healthy volunteers
Yes
Study drug
-
Sex
All
Actual Enrollment
2500
Study type
Observational
Age
N/A - 17 Years
Date
Study Start Date: 01 May 2008
Primary Completion Date: -
Study Completion Date: 01 Sept 2008
Study design
Allocation: -
Endpoint Classification: -
Intervention Model: -
Masking: -
Primary Purpose: -
Verification:
Verified 01 Jan 2015 by AstraZeneca Pharmaceuticals
Sponsors
AstraZeneca Pharmaceuticals
Collaborators
-
Inclusion and exclusion criteria
Loading...
No locations available
| Arms | Assigned Interventions |
|---|---|
| 1 children from 0 to 17 years old | - |
Contacts
Investigators
Principal Investigator
Frédéric GOTTRAND
CHRU Lille - France
